drugset / Trial / NCT01314092

Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula

NCT01314092 ↗

Phase 2 Terminated 15 enrolled Anterogen Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

Mesenchymal stem cells derived from adipose tissue are pluripotent to differentiate into myocytes, adipocytes or others. They have an immunosuppressive activity. Complex perianal fistula is difficult to cure and easy to relapse. Autologous adipose stem cells have shown efficacy and safety on Crohn's fistula in phase 1 study. Based on these results, the investigators would apply autologous adipose stem cells on complex perianal fistula to evaluate their efficacy and safety.

Timeline

Start
2011-01
Primary completion
2014-09
Completion
2014-09

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty recruiting subjects.”

Drugs

EvaluationDrugModalityDoseRoute
Subject ANTG-ASC Unknown 1e+07 cells —
Subject ANTG-ASC Unknown 2e+07 cells —

Indications